RACHEL K MINERAL CC PRESSED

Manufacturer
RACHEL K COSMETICS PTE. LTD.
Effective date
2012-09-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:33:04

Label at a glance#

ProductRACHEL K MINERAL CC PRESSED
Active ingredientTITANIUM DIOXIDE
Label structure8 sections

Indications and uses

HOW TO USE: Apply with Powder Brush or included sponge applicator. Can be used all over face, or just on oily spots.

Dosage and administration

HOW TO USE: Apply with Powder Brush or included sponge applicator. Can be used all over face, or just on oily spots.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredient: TITANIUM DIOXIDE 7%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients:
MICA, KAOLIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, ZINC STEARATE, SILICA, IRON OXIDE YELLOW, IRON OXIDE RED, DIISOSTEARYL MALATE, HYDROGENATED LECITHIN, IRON OXIDE BLACK, DIMETHICONE, TRIETHOXYCAPRYLYLSILANE, METHYLPARABEN, BUTYLPARABEN, ALLANTOIN, TOCOPHERYL ACETATE, BUTYROSPERMUM PARKII (SHEA BUTTER)

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

WARNINGS

WARNINGS SECTION

Caution:
For external use only.
Do not swallow.
Keep out of reach of children.
Avoid contact with eyes.
Do not store it in extreme high or low temperatures.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

HOW TO USE:
Apply with Powder Brush or included sponge applicator.
Can be used all over face, or just on oily spots.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

HOW TO USE:
Apply with Powder Brush or included sponge applicator.
Can be used all over face, or just on oily spots.

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53241-020-012019-11-13C16284748780-197449f38-b6ae-f6ea-e053-dbdaa90aa70348a63420-836b-4964-b458-bdc6288d02ec

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53241-020-01RACHEL K MINERAL CC PRESSED12 g in 1 CARTONPOWDER121

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53241-020RACHEL K MINERAL CC PRESSED (TITANIUM DIOXIDE) POWDER [RACHEL K COSMETICS PTE. LTD.]1Legacy NDC, 1 package rows20120920_48a63420-836b-4964-b458-bdc6288d02ec.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JP1
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O1
KAOLININACTIVE INGREDIENT24H4NWX5CO1
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7U1
ZINC STEARATEINACTIVE INGREDIENTH92E6QA4FV1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53241-02053241-020-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 43 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET, COATED / ORAL1.82 mgExact identifier — unii candidate
12 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COCAPSULE, COATED PELLETS / ORAL234 mgExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UINJECTION, EMULSION / INTRAVENOUS1.1 %w/vExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COPOWDER, FOR SUSPENSION / ORALNAExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UPOWDER / SUBLINGUAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COSYSTEM / TOPICAL420 mgExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UCREAM / TOPICAL3300 mgExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COCAPSULE, DELAYED RELEASE PELLETS / ORAL234 mgExact identifier — unii candidate
13 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVPOWDER / TOPICAL0.1 mg/mgExact identifier — unii candidate
12 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UPOWDER, FOR SUSPENSION / ORAL3390 mg/5mlExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVOINTMENT / TOPICALNAExact identifier — unii candidate
12 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UCAPSULE / ORAL4771 mgExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COCAPSULE / ORALNAExact identifier — unii candidate
13 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET / SUBLINGUAL2.5 mgExact identifier — unii candidate
12 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COPOWDER / TOPICAL10056 mgExact identifier — unii candidate
13 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COTABLET, EXTENDED RELEASE / ORAL66 mgExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY / TOPICAL540 mgExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVCREAM / TOPICAL6 %w/wExact identifier — unii candidate
12 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UAEROSOL, FOAM / TOPICAL10.87 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET / ORAL2 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET / BUCCAL2.5 mgExact identifier — unii candidate
12 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UGEL / TOPICAL12 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY, METERED / SUBLINGUAL110 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET, EXTENDED RELEASE / ORAL36 mgExact identifier — unii candidate
12 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET / ORAL72 mgExact identifier — unii candidate
12 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UOINTMENT / TOPICAL20 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UINJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS990.3 mgExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COCAPSULE, EXTENDED RELEASE / ORAL21 mgExact identifier — unii candidate
13 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVSHAMPOO / TOPICAL2 %w/wExact identifier — unii candidate
12 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COTABLET / ORAL150 mgExact identifier — unii candidate
13 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USUSPENSION / ORAL10170 mgExact identifier — unii candidate
18 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UTABLET, EXTENDED RELEASE / ORAL0.37 mgExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVTABLET, FILM COATED / ORAL15.2 mgExact identifier — unii candidate
12 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COSYRUP / ORAL10 mg/1mlExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USOLUTION / ORAL5566 mgExact identifier — unii candidate
18 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COTABLET, DELAYED RELEASE / ORAL18.5 mgExact identifier — unii candidate
13 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVCAPSULE / ORAL2.04 mgExact identifier — unii candidate
12 equally ranked IID candidates
KAOLINKAOLIN24H4NWX5COTABLET, COATED / ORAL52.44 mgExact identifier — unii candidate
13 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7ULOTION / TOPICAL7 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
ZINC STEARATEZINC STEARATEH92E6QA4FVSYRUP / ORALNAExact identifier — unii candidate
12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
854a0f8d-21b6-48de-b07b-7a287424df5748a63420-836b-4964-b458-bdc6288d02ec2012-09-20WarningsExact identifier
spl id: 854a0f8d-21b6-48de-b07b-7a287424df57
spl set id: 48a63420-836b-4964-b458-bdc6288d02ec

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.